Clinical Trial Update: Comparison Of Two Tablet Formulations Of SB-568859 [Phase 1]

View source ↗

Summary

Phase 1 study comparing two tablet formulations of SB-568859 for atherosclerosis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• SB-568859

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED